report thumbnailU.S. Platelet Rich Plasma Market

U.S. Platelet Rich Plasma Market Is Set To Reach USD Million  By 2033, Growing At A CAGR Of 17.2

U.S. Platelet Rich Plasma Market by Product (Pure Platelet Rich Plasma {Pure PRP}, Leukocyte-rich Platelet Rich Plasma {L-PRP}, Platelet Rich Fibrin {PRF}, Others), by Application (Orthopedics, Neurology, Cosmetics, Wound Care, Others), by End User (Hospital & ASCs, Specialty Clinics, Others), by Forecast 2025-2033


Base Year: 2024

150 Pages

Main Logo

U.S. Platelet Rich Plasma Market Is Set To Reach USD Million  By 2033, Growing At A CAGR Of 17.2

Main Logo

U.S. Platelet Rich Plasma Market Is Set To Reach USD Million  By 2033, Growing At A CAGR Of 17.2




Key Insights

The U.S. Platelet Rich Plasma Market size was valued at USD 117.2 USD Million in 2023 and is projected to reach USD 355.98 USD Million by 2032, exhibiting a CAGR of 17.2 % during the forecast period. PRP is a regenerative therapy that enriches the platelet in a patient's own blood to form a specific component which is used to treat such conditions and diseases that affect the forming of new cells and tissues. Classes can be divided into 2 types, the leukocyte-rich and leukocyte-poor, based on their levels of white blood cell counts. PRP factores high platelet concentration resulting in the release of growth factors responsible for tissue repair and regeneration. They can start with a simple orthopedics field, then, move on, to dermatology- and even cosmetics fields, like hair restoration. US, the thousand-dollar market allocates another $6.2 billion in medical expenses on basically minimally invasive treatments and advancing in medical technology as well. However, it also has its downsides in the form of regulations and reimbursement policies that restrict the market growth.

U.S. Platelet Rich Plasma Market Research Report - Market Size, Growth & Forecast

U.S. Platelet Rich Plasma Trends

  • Rising demand for non-surgical and minimally invasive treatments
  • Growing popularity of PRP therapy for cosmetic applications
  • Technological advancements in PRP preparation and delivery systems

Driving Forces: What's Propelling the U.S. Platelet Rich Plasma Market

  • Growing prevalence of chronic diseases
  • Increased awareness of PRP therapy
  • Technological advancements
  • Government initiatives and funding

Challenges and Restraints in U.S. Platelet Rich Plasma Market

  • High cost of PRP therapy: PRP therapy can be expensive, particularly for patients without insurance coverage.
  • Lack of standardized protocols: Different healthcare providers may use varying PRP preparation and administration techniques, leading to inconsistency in treatment outcomes.
  • Regulatory hurdles: The Food and Drug Administration (FDA) has yet to approve PRP for specific medical indications, which can create uncertainty among clinicians and patients.
  • Limited insurance coverage: Many insurance companies do not cover PRP therapy, making it financially burdensome for patients.
  • Potential risks: As with any medical procedure, PRP therapy carries potential risks such as infection, pain, and tissue damage if not performed correctly.
  • Need for further research: More clinical studies and research are necessary to establish the long-term efficacy and safety of PRP therapy for various medical conditions.

Emerging Trends in U.S. Platelet Rich Plasma

  • Development of new PRP preparation methods
  • Growing use of PRP in combination with other therapies
  • Advancements in PRP delivery systems

Growth Catalysts in the U.S. Platelet-Rich Plasma Industry

U.S. Platelet Rich Plasma Market Growth
  • Increasing number of research studies supporting the benefits of PRP therapy
  • Entry of major players into the market
  • Rising demand for aesthetic procedures

Market Segmentation: U.S. Platelet Rich Plasma Analysis

Product:

  • Pure Platelet Rich Plasma (Pure PRP)
  • Leukocyte-rich Platelet Rich Plasma (L-PRP)
  • Platelet Rich Fibrin (PRF)

Application:

  • Orthopedics
  • Neurology
  • Cosmetics
  • Wound Care

End User:

  • Hospital & ASCs
  • Specialty Clinics

Leading Players in the U.S. Platelet Rich Plasma Market

Significant Developments in the U.S. Platelet-Rich Plasma Sector

  • June 2023: Isto Biologics launched Precise, a brand-new technology that delivers a final platelet-rich plasma product with precision cellular fractions upon concentration.
  • July 2021: Arthrex, Inc. entered into a strategic agreement with Celularity to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedic surgery and sports medicine in the U.S.
  • July 2021: Exactech, Inc. partnered with RTI Surgical to supply and develop biologic products, such as bone substitutes.

Comprehensive Coverage U.S. Platelet Rich Plasma Market Report

  • DROCT Analysis: Drivers, Restraints, Opportunities, Challenges, and Threats
  • Pricing Analysis: Price Trends, Market Segments, and Geographic Variations
  • Import and Export Analysis: Historical Data, Market Volume, and Value
  • Segmentation: Product, Application, End User, and Geography
  • Patent/Trademark Analysis: Recent Filings, Granted Patents, and Pending Applications


U.S. Platelet Rich Plasma Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2019-2033
Base Year 2024
Estimated Year 2025
Forecast Period2025-2033
Historical Period2019-2024
Growth RateCAGR of 17.2% from 2019-2033
Segmentation
    • By Product
      • Pure Platelet Rich Plasma {Pure PRP}
      • Leukocyte-rich Platelet Rich Plasma {L-PRP}
      • Platelet Rich Fibrin {PRF}
      • Others
    • By Application
      • Orthopedics
      • Neurology
      • Cosmetics
      • Wound Care
      • Others
    • By End User
      • Hospital & ASCs
      • Specialty Clinics
      • Others
  • By Geography


Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Rising Technological Developments in Products to Propel Market Growth
      • 3.3. Market Restrains
        • 3.3.1. Stringent Regulatory Scenario and Relevant Side-Effects to Impede Growth Prospects
      • 3.4. Market Trends
        • 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. U.S. Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2031
    • 5.1. Market Analysis, Insights and Forecast - by Product
      • 5.1.1. Pure Platelet Rich Plasma {Pure PRP}
      • 5.1.2. Leukocyte-rich Platelet Rich Plasma {L-PRP}
      • 5.1.3. Platelet Rich Fibrin {PRF}
      • 5.1.4. Others
    • 5.2. Market Analysis, Insights and Forecast - by Application
      • 5.2.1. Orthopedics
      • 5.2.2. Neurology
      • 5.2.3. Cosmetics
      • 5.2.4. Wound Care
      • 5.2.5. Others
    • 5.3. Market Analysis, Insights and Forecast - by End User
      • 5.3.1. Hospital & ASCs
      • 5.3.2. Specialty Clinics
      • 5.3.3. Others
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1.
  6. 6. Northeast U.S. Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2031
    • 7. Southeast U.S. Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2031
      • 8. Midwest U.S. Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2031
        • 9. Southwest U.S. Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2031
          • 10. West U.S. Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2031
            • 11. Competitive Analysis
              • 11.1. Market Share Analysis 2024
                • 11.2. Company Profiles
                  • 11.2.1 Arthrex Inc. (U.S.)
                    • 11.2.1.1. Overview
                    • 11.2.1.2. Products
                    • 11.2.1.3. SWOT Analysis
                    • 11.2.1.4. Recent Developments
                    • 11.2.1.5. Financials (Based on Availability)
                  • 11.2.2 Zimmer Biomet (U.S.)
                    • 11.2.2.1. Overview
                    • 11.2.2.2. Products
                    • 11.2.2.3. SWOT Analysis
                    • 11.2.2.4. Recent Developments
                    • 11.2.2.5. Financials (Based on Availability)
                  • 11.2.3 Isto Biologics (U.S.)
                    • 11.2.3.1. Overview
                    • 11.2.3.2. Products
                    • 11.2.3.3. SWOT Analysis
                    • 11.2.3.4. Recent Developments
                    • 11.2.3.5. Financials (Based on Availability)
                  • 11.2.4 ThermoGenesis Holdings Inc. (U.S.)
                    • 11.2.4.1. Overview
                    • 11.2.4.2. Products
                    • 11.2.4.3. SWOT Analysis
                    • 11.2.4.4. Recent Developments
                    • 11.2.4.5. Financials (Based on Availability)
                  • 11.2.5 Exactech Inc. (U.S.)
                    • 11.2.5.1. Overview
                    • 11.2.5.2. Products
                    • 11.2.5.3. SWOT Analysis
                    • 11.2.5.4. Recent Developments
                    • 11.2.5.5. Financials (Based on Availability)
                  • 11.2.6 EmCyte Corporation (U.S.)
                    • 11.2.6.1. Overview
                    • 11.2.6.2. Products
                    • 11.2.6.3. SWOT Analysis
                    • 11.2.6.4. Recent Developments
                    • 11.2.6.5. Financials (Based on Availability)
                  • 11.2.7 Stryker (U.S.)
                    • 11.2.7.1. Overview
                    • 11.2.7.2. Products
                    • 11.2.7.3. SWOT Analysis
                    • 11.2.7.4. Recent Developments
                    • 11.2.7.5. Financials (Based on Availability)
                  • 11.2.8 Medical Devices Business Services Inc. (Johnson & Johnson Services
                    • 11.2.8.1. Overview
                    • 11.2.8.2. Products
                    • 11.2.8.3. SWOT Analysis
                    • 11.2.8.4. Recent Developments
                    • 11.2.8.5. Financials (Based on Availability)
                  • 11.2.9 Inc.) (U.S.)
                    • 11.2.9.1. Overview
                    • 11.2.9.2. Products
                    • 11.2.9.3. SWOT Analysis
                    • 11.2.9.4. Recent Developments
                    • 11.2.9.5. Financials (Based on Availability)
                  • 11.2.10 Terumo Corporation (Japan)
                    • 11.2.10.1. Overview
                    • 11.2.10.2. Products
                    • 11.2.10.3. SWOT Analysis
                    • 11.2.10.4. Recent Developments
                    • 11.2.10.5. Financials (Based on Availability)

            List of Figures

            1. Figure 1: U.S. Platelet Rich Plasma Market Revenue Breakdown (USD Million, %) by Product 2024 & 2032
            2. Figure 2: U.S. Platelet Rich Plasma Market Share (%) by Company 2024

            List of Tables

            1. Table 1: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Region 2019 & 2032
            2. Table 2: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Product 2019 & 2032
            3. Table 3: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Application 2019 & 2032
            4. Table 4: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by End User 2019 & 2032
            5. Table 5: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Region 2019 & 2032
            6. Table 6: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Country 2019 & 2032
            7. Table 7: Northeast U.S. Platelet Rich Plasma Market Revenue (USD Million) Forecast, by Application 2019 & 2032
            8. Table 8: Southeast U.S. Platelet Rich Plasma Market Revenue (USD Million) Forecast, by Application 2019 & 2032
            9. Table 9: Midwest U.S. Platelet Rich Plasma Market Revenue (USD Million) Forecast, by Application 2019 & 2032
            10. Table 10: Southwest U.S. Platelet Rich Plasma Market Revenue (USD Million) Forecast, by Application 2019 & 2032
            11. Table 11: West U.S. Platelet Rich Plasma Market Revenue (USD Million) Forecast, by Application 2019 & 2032
            12. Table 12: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Product 2019 & 2032
            13. Table 13: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Application 2019 & 2032
            14. Table 14: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by End User 2019 & 2032
            15. Table 15: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Country 2019 & 2032


            Methodology

            Step 1 - Identification of Relevant Samples Size from Population Database

            Step Chart
            Bar Chart
            Method Chart

            Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

            Approach Chart
            Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

            Note*: In applicable scenarios

            Step 3 - Data Sources

            Primary Research

            • Web Analytics
            • Survey Reports
            • Research Institute
            • Latest Research Reports
            • Opinion Leaders

            Secondary Research

            • Annual Reports
            • White Paper
            • Latest Press Release
            • Industry Association
            • Paid Database
            • Investor Presentations
            Analyst Chart

            Step 4 - Data Triangulation

            Involves using different sources of information in order to increase the validity of a study

            These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

            Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

            During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

            Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

            Frequently Asked Questions

            1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Platelet Rich Plasma Market?

            The projected CAGR is approximately 17.2%.

            2. Which companies are prominent players in the U.S. Platelet Rich Plasma Market?

            Key companies in the market include Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), Isto Biologics (U.S.), ThermoGenesis Holdings, Inc. (U.S.), Exactech, Inc. (U.S.), EmCyte Corporation (U.S.), Stryker (U.S.), Medical Devices Business Services, Inc. (Johnson & Johnson Services, Inc.) (U.S.), Terumo Corporation (Japan).

            3. What are the main segments of the U.S. Platelet Rich Plasma Market?

            The market segments include Product, Application, End User.

            4. Can you provide details about the market size?

            The market size is estimated to be USD 117.2 USD Million as of 2022.

            5. What are some drivers contributing to market growth?

            Rising Technological Developments in Products to Propel Market Growth.

            6. What are the notable trends driving market growth?

            Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

            7. Are there any restraints impacting market growth?

            Stringent Regulatory Scenario and Relevant Side-Effects to Impede Growth Prospects.

            8. Can you provide examples of recent developments in the market?

            June 2023- Isto Biologics launched Precise, a brand-new technology that delivers a final platelet rich plasma product with precision cellular fractions upon concentration. This product allows physicians and surgeons to customize their PRP to fit patient needs.

            9. What pricing options are available for accessing the report?

            Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

            10. Is the market size provided in terms of value or volume?

            The market size is provided in terms of value, measured in USD Million.

            11. Are there any specific market keywords associated with the report?

            Yes, the market keyword associated with the report is "U.S. Platelet Rich Plasma Market," which aids in identifying and referencing the specific market segment covered.

            12. How do I determine which pricing option suits my needs best?

            The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

            13. Are there any additional resources or data provided in the U.S. Platelet Rich Plasma Market report?

            While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

            14. How can I stay updated on further developments or reports in the U.S. Platelet Rich Plasma Market?

            To stay informed about further developments, trends, and reports in the U.S. Platelet Rich Plasma Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

            Related Reports


            About Market Research Forecast

            MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

            Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

            We use cookies to enhance your experience.

            By clicking "Accept All", you consent to the use of all cookies.

            Customize your preferences or read our Cookie Policy.